Literature DB >> 15234983

Analysis of alpha-synuclein-associated proteins by quantitative proteomics.

Yong Zhou1, Guangyu Gu, David R Goodlett, Terry Zhang, Catherine Pan, Thomas J Montine, Kathleen S Montine, Ruedi H Aebersold, Jing Zhang.   

Abstract

To identify the proteins associated with soluble alpha-synuclein (AS) that might promote AS aggregation, a key event leading to neurodegeneration, we quantitatively compared protein profiles of AS-associated protein complexes in MES cells exposed to rotenone, a pesticide that produces parkinsonism in animals and induces Lewy body (LB)-like inclusions in the remaining dopaminergic neurons, and to vehicle. We identified more than 250 proteins associated with Nonidet P-40 soluble AS, and demonstrated that at least 51 of these proteins displayed significant differences in their relative abundance in AS complexes under conditions where rotenone was cytotoxic and induced formation of cytoplasmic inclusions immunoreactive to anti-AS. Overexpressing one of these proteins, heat shock protein (hsp) 70, not only protected cells from rotenone-mediated cytotoxicity but also decreased soluble AS aggregation. Furthermore, the protection afforded by hsp70 transfection appeared to be related to suppression of rotenone-induced oxidative stress as well as mitochondrial and proteasomal dysfunction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15234983     DOI: 10.1074/jbc.M405456200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

Review 1.  Protein degradation pathways in Parkinson's disease: curse or blessing.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  Acta Neuropathol       Date:  2012-06-29       Impact factor: 17.088

2.  Identification of ciliary neurotrophic factor receptor alpha as a mediator of neurotoxicity induced by alpha-synuclein.

Authors:  Jun Liu; Min Shi; Zhen Hong; JianPeng Zhang; Joshua Bradner; Thomas Quinn; Richard P Beyer; Patrick L Mcgeer; ShengDi Chen; Jing Zhang
Journal:  Proteomics       Date:  2010-06       Impact factor: 3.984

3.  LRRK2 function on actin and microtubule dynamics in Parkinson disease.

Authors:  Loukia Parisiadou; Huaibin Cai
Journal:  Commun Integr Biol       Date:  2010-09

Review 4.  Molecular chaperones in Parkinson's disease--present and future.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

5.  Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion.

Authors:  Robert C Rostomily; Donald E Born; Richard P Beyer; Jinghua Jin; Ellsworth C Alvord; Andrei M Mikheev; Russell T Matthews; Catherine Pan; Leila Khorasani; Josh A Sonnen; Thomas J Montine; Min Shi; Jing Zhang
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

Review 6.  Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity.

Authors:  F Tribl; K Marcus; G Bringmann; H E Meyer; M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2006-07-13       Impact factor: 3.575

Review 7.  Neuroproteomics as a promising tool in Parkinson's disease research.

Authors:  Ilse S Pienaar; William M U Daniels; Jürgen Götz
Journal:  J Neural Transm (Vienna)       Date:  2008-06-04       Impact factor: 3.575

Review 8.  Neuroproteomics approaches to decipher neuronal regeneration and degeneration.

Authors:  Faneng Sun; Valeria Cavalli
Journal:  Mol Cell Proteomics       Date:  2009-12-17       Impact factor: 5.911

9.  Assessing the subcellular dynamics of alpha-synuclein using photoactivation microscopy.

Authors:  Susana Gonçalves; Tiago Fleming Outeiro
Journal:  Mol Neurobiol       Date:  2013-02-08       Impact factor: 5.590

Review 10.  Expanding role of molecular chaperones in regulating α-synuclein misfolding; implications in Parkinson's disease.

Authors:  Sandeep K Sharma; Smriti Priya
Journal:  Cell Mol Life Sci       Date:  2016-08-13       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.